Science Explorer Back to mapMap
Hospital / health system · Portland · United States

Compass Oncology

Research works
75
▼ 34% vs 2018-21
Citations
1.3k
17.2 per fractional work
Top-10% rate
13.8%
all institutions 10.0%
Open access
44%
world 40%
International
16%
world 18%

Not ranked overall: Compass Oncology is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Compass Oncology work in?

In all years, 76% of research at Compass Oncology is in Health Sciences, 16% in Life Sciences. Its largest fields are Medicine (73%), Biochemistry, Genetics and Molecular Biology (14%), Economics, Econometrics and Finance (4%). It does 2.9× the world's share of Health Sciences.

Health Sciences: 57 fractional works · 75.9% of its workMedicine: 55 fractional works · 72.5% of its workOncology: 9 fractional works · 12.5% of its workSurgery: 6 fractional works · 7.6% of its workPublic Health, Environmental and Occupational Health: 5 fractional works · 6.7% of its workPulmonary and Respiratory Medicine: 5 fractional works · 6.5% of its workPathology and Forensic Medicine: 4 fractional works · 5.3% of its workDermatology: 4 fractional works · 4.6% of its workEpidemiology: 3 fractional works · 4.4% of its workGenetics: 3 fractional works · 4.1% of its workObstetrics and Gynecology: 3 fractional works · 3.7% of its workHematology: 3 fractional works · 3.6% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 2.6% of its workRheumatology: 1 fractional works · 1.8% of its workPhysiology: 1 fractional works · 1.6% of its workReproductive Medicine: 1 fractional works · 1.5% of its workNeurology: 1 fractional works · 0.8% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.6% of its workGastroenterology: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workNephrology: 0 fractional works · 0.4% of its workHepatology: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.3% of its workPsychiatry and Mental health: 0 fractional works · 0.3% of its workRehabilitation: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 1.0% of its workHealth Professions: 2 fractional works · 2.9% of its workGeneral Health Professions: 1 fractional works · 1.4% of its workSpeech and Hearing: 1 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.2% of its workPeriodontics: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 12 fractional works · 16.2% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 13.9% of its workCancer Research: 4 fractional works · 5.2% of its workGenetics: 4 fractional works · 4.7% of its workMolecular Biology: 3 fractional works · 3.4% of its workBiotechnology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 1.4% of its workImmunology: 1 fractional works · 1.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.2% of its workCognitive Neuroscience: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workSocial Sciences: 5 fractional works · 6.1% of its workEconomics, Econometrics and Finance: 3 fractional works · 3.5% of its workEconomics and Econometrics: 3 fractional works · 3.5% of its workSocial Sciences: 2 fractional works · 2.1% of its workSociology and Political Science: 1 fractional works · 1.6% of its workCultural Studies: 0 fractional works · 0.5% of its workPsychology: 0 fractional works · 0.4% of its workClinical Psychology: 0 fractional works · 0.4% of its workArts and Humanities: 0 fractional works · 0.1% of its workPhysical Sciences: 1 fractional works · 1.9% of its workEnvironmental Science: 1 fractional works · 1.1% of its workManagement, Monitoring, Policy and Law: 1 fractional works · 0.7% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysics and Astronomy: 0 fractional works · 0.3% of its workRadiation: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.2% of its workStatistics and Probability: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workComputer Science: 0 fractional works · 0.1% of its workALL ITS WORKCompass Oncology75fractional works, all years
Life Sciences16%Physical Sciences2%Health Sciences76%Social Sciences6%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine5572.5%
    2. Health Professions22.9%
    3. Dentistry00.2%
    4. Nursing00.1%
    5. Veterinary00.1%
    1. Biochemistry, Genetics and Molecular Biology1013.9%
    2. Immunology and Microbiology11.4%
    3. Pharmacology, Toxicology and Pharmaceutics00.6%
    4. Neuroscience00.2%
    5. Agricultural and Biological Sciences00.1%
    1. Economics, Econometrics and Finance33.5%
    2. Social Sciences22.1%
    3. Psychology00.4%
    4. Arts and Humanities00.1%
    1. Environmental Science11.1%
    2. Physics and Astronomy00.3%
    3. Mathematics00.2%
    4. Earth and Planetary Sciences00.1%
    5. Computer Science00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.61× its world share, 2 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 5.66× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.06× its world share, 0 worksComputer SciencePhysics and Astronomy: 0.15× its world share, 0 worksPhysics and AstronomyDentistry: 0.59× its world share, 0 worksDentistryHealth Professions: 0.41× its world share, 0 worksHealth ProfessionsMedicine: 3.73× its world share, 12 worksMedicineVeterinary: 4.89× its world share, 0 worksVeterinaryArts and Humanities: 0.17× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 3.70× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.7×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics5.66×0 works
  2. Veterinary4.89×0 works
  3. Medicine3.73×12 works
  4. Economics, Econometrics and Finance3.70×1 works
  5. Biochemistry, Genetics and Molecular Biology2.61×2 works
  6. Dentistry0.59×0 works
  7. Health Professions0.41×0 works
  8. Arts and Humanities0.17×0 works
  9. Physics and Astronomy0.15×0 works
  10. Agricultural and Biological Sciences0.14×0 works
  11. Computer Science0.06×0 works
  12. Social Sciences0.04×0 works

Who are the top researchers at Compass Oncology?

Ranked on the quality score, Ian D. Schnadig, Spencer H. Shao and Michael J. Klepper lead among researchers whose main affiliation is Compass Oncology.

  1. 1 Ian D. Schnadig United States · #364,259 worldwide 2.4k citations · 64 works
  2. 2 Spencer H. Shao United States · #837,698 worldwide 2.2k citations · 23 works
  3. 3 Michael J. Klepper United States · #3,778,190 worldwide 140 citations · 19 works
  4. 4 Lucy R. Langer United States · #3,815,329 worldwide 73 citations · 20 works
  5. 5 Christof P Erickson United States · #4,535,174 worldwide 414 citations · 39 works
  6. 6 Antoanella Calame United States · #5,042,297 worldwide 891 citations · 89 works
  7. 7 Jay Clarence Andersen United States · #5,064,035 worldwide 102 citations · 55 works
All ranked researchers at Compass Oncology

What are the most cited papers from Compass Oncology?

The most cited paper from Compass Oncology is "Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial" (Louis Fehrenbacher, Alexander I. Spira, Marcus D. Ballinger et al., 2016), with 2,823 citations. Next come "Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA" (1,567) and "Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set" (1,027).

Most cited papers
#PaperReleasedCitations
1 Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial Louis Fehrenbacher, Alexander I. Spira, Marcus D. Ballinger et al. · The Lancet 9 Mar 2016 2,823
2 Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA M.C. Liu et al. · Annals of Oncology Open access159 authors 30 Mar 2020 1,567
3 Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set Eric A. Klein, Donald Richards, Allen Lee Cohn et al. · Annals of Oncology Open access 24 Jun 2021 1,027
4 Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study Ian W. Flinn, Richard van der Jagt, Brad S. Kahl et al. · Blood Open access 4 Mar 2014 646
5 Boundary spanning at the science–policy interface: the practitioners’ perspectives ANGELA T. BEDNAREK, Carina A. Wyborn, Christopher Cvitanovic et al. · Sustainability Science Open access 27 Mar 2018 342
All 60 most cited papers, with filters and sorting

Which keywords describe research at Compass Oncology?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Prognostic Factors, Survival Analysis, Rituximab, Palliative Care, Precision Medicine and Quality of Life.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy7▲ 13×19 topics
  2. Clinical Practice Guidelines6▲ 14×8 topics
  3. Prognostic Factors6▲ 17×12 topics
  4. Survival Analysis5▲ 27×6 topics
  5. Quality of Life5▲ 4.9×13 topics
  6. Rituximab5▲ 40×3 topics
  7. Palliative Care4▲ 34×3 topics
  8. Precision Medicine4▲ 17×5 topics
  9. Breast Cancer4▲ 18×7 topics
  10. End-of-Life4▲ 60×2 topics
  11. Immunotherapy4▲ 7.0×10 topics
  12. Clinical Trials3▲ 7.3×11 topics
  13. Radiation Therapy3▲ 31×4 topics
  14. Targeted Therapy3▲ 21×4 topics
  15. Sentinel Lymph Node Biopsy3▲ 63×2 topics
  16. Cervical Cancer3▲ 40×2 topics
  17. Radiotherapy3▲ 10×10 topics
  18. Molecular Classification3▲ 25×2 topics
  19. Advance Care Planning3▲ 64×1 topic
  20. Cancer Risk3▲ 14×4 topics
  21. Family Perspectives3▲ 64×1 topic
  22. PET Imaging3▲ 16×4 topics
  23. Robotic Surgery3▲ 26×2 topics
  24. Brachytherapy2▲ 90×1 topic
  25. Endometrial Carcinoma2▲ 90×1 topic
  26. Lymphoma2▲ 23×2 topics
  27. Chronic Lymphocytic Leukemia2▲ 66×1 topic
  28. Genomic Aberrations2▲ 66×1 topic
  29. Genomic Instability2▲ 26×3 topics
  30. Metastasis2▲ 9.5×7 topics
  31. Molecular Subtypes2▲ 37×2 topics
  32. Cancer Genomics2▲ 56×1 topic
  33. Metastatic Breast Cancer2▲ 46×2 topics
  34. Mutational Signatures2▲ 56×1 topic
  35. Neoadjuvant Therapy2▲ 14×4 topics
  36. Genetic Testing2▲ 18×2 topics
  37. Gene Expression Profiling2▲ 29×2 topics
  38. Molecular Profiling2▲ 24×2 topics
  39. Ovarian Cancer2▲ 30×3 topics
  40. Genetic Pathogenesis2▲ 44×1 topic

Which research topics does Compass Oncology publish most on?

By volume in 2022-now: Chronic Myeloid Leukemia Treatments, Colorectal Cancer Treatments and Studies, Chronic Lymphocytic Leukemia Research and Economic and Financial Impacts of Cancer.

  1. 1 Chronic Myeloid Leukemia Treatments Hematology 1 works
  2. 2 Colorectal Cancer Treatments and Studies Oncology 1 works
  3. 3 Chronic Lymphocytic Leukemia Research Genetics 1 works
  4. 4 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  5. 5 Cancer Genomics and Diagnostics Cancer Research 1 works
  6. 6 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
  7. 7 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  8. 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  9. 9 BRCA gene mutations in cancer Genetics 0 works
  10. 10 Pharmaceutical Economics and Policy Economics and Econometrics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.2%not open55.8%

World: 40% of research is openly available.

with international co-authors16.1%domestic only83.9%

World: 18% is written across borders.

How has Compass Oncology's research output changed?

Output in 2022-2025 was 34% lower than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Compass Oncology as a percentage of every work published that year, 0.000082% in 2024.

still counting0.00010%0.00020%Compass Oncology0.000055% in 2025200020102020

Fractional works of Compass Oncology over all fractional works that year. How the balance of science has shifted.

Other research institutions in Portland

All research institutions in Portland

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Compass Oncology. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.